SCRI operates a distributed network of 1,300+ physicians running oncology trials across 200+ locations. The tech stack—AWS, Azure, SAP, Salesforce, Databricks, Veeva Vault, ServiceNow—reflects a hybrid clinical + financial operations model. Hiring skews heavily toward research staff (29 roles), with emerging data (3) and engineering (2) investment, suggesting SCRI is automating trial workflows and data pipelines to manage the complexity of multisite trial coordination and regulatory deadlines.
Sarah Cannon Research Institute conducts community-based oncology clinical trials, having executed over 850 first-in-human studies since 1993. The organization operates a network of 1,300+ physicians enrolled across 200+ trial sites in 20+ U.S. states. SCRI's research has contributed to the majority of FDA-approved cancer therapies over the past decade. The company serves drug developers, academic researchers, and patient populations seeking access to novel oncology treatments. Current operational focus spans trial enrollment, site startup, patient outcomes tracking, and the data infrastructure required to manage multisite regulatory compliance and trial data quality.
SCRI is a leading oncology research organization conducting community-based clinical trials. It has completed over 850 first-in-human trials and contributed to the development of the majority of new FDA-approved cancer therapies in the past decade.
SCRI operates over 200 clinical trial locations across 20+ U.S. states, with a network of more than 1,300 active physicians enrolling patients into trials.
SCRI's core stack includes AWS, Azure, SAP, Salesforce, Databricks, Veeva Vault, ServiceNow, and Alation. The mix reflects clinical trial management, financial operations, and emerging data analytics capabilities.
Other companies in the same industry, closest in size